Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study

European Journal of Cancer and Clinical Oncology

Volumn 20, Issue 8, 1984, Pages 1025-1032

  Elliott, J A ^a   Ahmedzai, S ^b   Hole, D ^c   Dorward, A J ^a   Stevenson, R D ^b   Kaye, S B ^d   Banham, S W ^b   Stack, B H R ^a   Calman, K C ^d  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c RUCHILL HOSPITAL   (United Kingdom)

^d GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PHENOTHIAZINE DERIVATIVE; VINDESINE;

ADVERSE DRUG REACTION; ANOREXIA; ATAXIA; AUDITORY SYSTEM; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; GASTROINTESTINAL TOXICITY; HEARING IMPAIRMENT; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NERVOUS SYSTEM; NEUROPATHY; NEUROTOXICITY; OTOTOXICITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SQUAMOUS CELL CARCINOMA; THERAPY; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RANDOM ALLOCATION; VINBLASTINE; VINDESINE;

EID: 0021238424     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(84)90104-4     Document Type: Article

References (24)

1. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung
2. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma
3. Vindesine: an effective agent in the treatment of non-small cell lung cancer
4. Vindesine in the treatment of squamous cell carcinoma adenocarcinoma and large cell carcinoma of the lung
5. A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer
6. Phase II evaluation of cis-diamminedichloroplatinum (II) in lung cancer
7. Cis-dichlorodiammineplatinum (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum (II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung
8. Phase II study of high dose cis-dichlorodiammineplatinum (II) in the treatment of non-small cell lung cancer
9. High dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium)
10. Efficacy study of intensive cisplatin therapy in advanced non-small cell bronchogenic carcinoma
11. High-dose cisplatin for lung cancer
12. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules
13. A role of cis-dichlorodiammineplatinum (II) in squamous cell lung cancer
14. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer
15. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma
16. Cis-dichlorodiammineplatinum (II), adriamycin, cyclophosphamide, CCNU and vincristine in non-small cell lung carcinoma: a preliminary report
17. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer
18. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer
19. Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma
20. Cisplatin and etoposide with or without vindesine in non-small cell lung cancer
21. Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung; a Southwest Oncology Group Study
22. Commentary: current status of chemotherapy for non-small cell lung cancer
23. High dose cis-platinum diamminedichloride: amelioration of renal toxicity by mannitol diuresis